Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1, Clinical Trial Optional) is sponsored by National Human Genome Research Institute (NHGRI). Supports building partnerships and broadening perspectives to advance ELSI research in genomics and related fields, including ethical issues in AI applications.

BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics Applications are open for the Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional (RFA-HG-24-026).

This opportunity supports organizations interested in advancing scholarship and capacity in ELSI research related to advances in genetics and genomics. Eligible applicants must be domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (FY 2023–2025).

Eligible applicants may propose partnerships with other organizations that receive more than $30 million per year in NIH funding. Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible to apply.

The goals of the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program are to: Enhance ELSI research teams through partnerships with relevant communities Build ELSI research capacity Expand the ELSI workforce Collectively, these goals will broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in ELSI research This program is funded by the National Human Genome Research Institute’s (NHGRI) ELSI Research Program.

Since 1990, the ELSI Research Program has funded research, research training, resource development, and other activities addressing the ethical, legal, and social implications of advances in genetics and genomics. Detailed application requirements and program information are available in the Notice of Funding Opportunity RFA-HG-24-026 , which includes an overview diagram of all application elements.

Frequently Asked Questions and a recorded program presentation are also available online. Per NIH notice NOT-OD-26-019, letters of intent are no longer required. For additional questions or to discuss organizational interests, please contact Dr. Rene Sterling at rene.

sterling@nih. gov. Notice of Funding Opportunity RFA-HG-24-026 BBAER Frequently Asked Questions BBAER Pre-Application Recorded Webinar AIM-AHEAD Research Spotlight Series: Showcasing Innovative Research Across the Consortium Find out more about how AIM-AHEAD Consortium Development Program participants Yanmin Gong (PhD) and Feifan Liu (PhD) are advancing healthcare through AI/ML-driven research.

Beyond the Program: Success Stories from the AIM-AHEAD Program for Artificial Intelligence Readiness (PAIR) Read inspiring success stories from AIM-AHEAD PAIR awardees who are building AI/ML research capacity, launching innovative labs, and creating new opportunities for students and collaborators at institutions across the country.

More than 50 AIM-AHEAD Trainees Present In-Progress Research at the Bridge2AI 2026 All-Hands Meeting April 28-29 Leading experts, researchers, trainees, and partners from across the biomedical and artificial intelligence and machine learning (AI/ML) community convened for the Bridge2AI All-Hands meeting.